This insider cluster is routine and non-informative. No trading action is warranted based on these small director sales. Monitor for any upcoming corporate events (e.g., earnings, pipeline updates) that could provide a catalyst, but this filing alone does not change the outlook.
TVTX drugs
TVTX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 17 $54.14entry
- T+1 · 5mo ago +1.87%α +1.09% · $55.15
- T+5 · 5mo ago +6.56%α +7.60% · $57.69
- T+20 · 4mo ago +2.11%α +0.79% · $55.28
- T+60 · 2mo ago +22.22%α +19.07% · $66.17
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two directors of Travere Therapeutics (TVTX) exercised stock options and immediately sold the resulting shares on June 12, 2026, for a total of ~$726K in open-market sales. The combined sales represent only 0.015% of the company's $5.0B market cap, making this a routine, liquidity-driven transaction with no material informational content.
Key Financial Metrics
Key Facts
- Directors Timothy Coughlin and Roy D. Baynes each exercised stock options and sold shares on June 12, 2026.
- Coughlin sold 10,000 shares at $50.07 for $500,747; Baynes sold 4,500 shares at $50.00 for $225,000.
- Total open-market sales: $725,747, or ~0.015% of TVTX's $5.0B market cap.
- Both sales followed option exercises (cash and non-cash), indicating a typical exercise-and-sell pattern rather than a bearish signal.
- No C-suite executives participated in the cluster; only directors transacted.
Financial Impact
Trivial, $726K in sales is immaterial relative to $5.0B market cap.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TVTX-1781642857007 |
Track record
21 reports on TVTX
8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
- Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
- Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 2/10 Viewing Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
- Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers